As of May 03
| +0.0095 / +1.03%|
The 1 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +222.58% increase from the last price of 0.93.
The current consensus among 1 polled investment analysts is to Buy stock in Aveo Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.